Brief: Aequus Pharmaceuticals says advancement of clobazam transdermal patent application
29/07/2016 14:58
July 29 (Reuters) - Aequus Pharmaceuticals Inc AQS.V says
-
* Aequus Pharmaceuticals Inc says advancement of clobazam
transdermal patent application
Source text for Eikon: urn:newsml:reuters.com:*:nMKWtbpFla
Further company coverage: AQS.V
((Bengaluru Newsroom: +1 646 223 8780))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange